Yuliana Indriati, President Director of PT Kalbe Genexine Biologics is speaking at Phar-East 2018

PT Kalbe Genexine Biologics on Indonesia biologics landscape

Emily Event News Leave a Comment

As you know, PT Kalbe Farma Tbk (“Kalbe”) was established in 1966 and headquartered in Jakarta. It is the largest, publicly listed pharmaceuticals company in Southeast Asia with over US$6 billion in market capitalization and revenues of over IDR 7 trillion (2016). Partnering with Genexine, Inc (KOSDAQ, 095700), another listed company of 20 years history, specialising in clinical stage biotechnology with a focus on …